News
4don MSN
Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
According to a study funded by Eli Lilly, the trial revealed that participants taking tirzepatide, the drug sold as ...
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results